Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temozolomide in MGMT-methylated advanced aerodigestive tract cancers
NCT00423150Phase 2Terminated
- Sponsor
- Merck & Co.
- Start
- Jan 2007
- Primary completion
- Jun 2009
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of temozolomide in colorectal cancer (CRC), head and neck cancer (HNC), non-small cell lung cancer (NSCLC), esophageal cancer, sponsored by Merck & Co.. Started Jan 2007; status: terminated.
02
Drugs
temozolomide
03
Conditions
colorectal cancer (CRC)head and neck cancer (HNC)non-small cell lung cancer (NSCLC)esophageal cancer
Beyond the preview
Go deeper on NCT00423150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00423150.